Home NDC 67877-184 Granisetron Hydrochloride
Product NDC 67877-184
11-digit product format 678770184
Labeler code 67877
Product ID 67877-184_de33da5e-1833-4875-915c-578380409b54
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name Granisetron Hydrochloride
Dosage form TABLET
Route ORAL
Labeler Ascend Laboratories, LLC
Application ANDA078969
Marketing category ANDA
Marketing start 2010-01-01
Marketing end 0000-00-00
Substance GRANISETRON HYDROCHLORIDE
Active strength 1 mg/1
Pharmacologic classes Serotonin 3 Receptor Antagonists [MoA],Serotonin-3 Receptor Antagonist [EPC]
NDC exclude flag E
Listing certified through 2017-12-31
Current FDA listing Historical FDA.report record
Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 2 · 66 matching rows.
View current auxiliary records. · View the auxiliary file history.
Source provenance: Browse the complete Orange Book source catalog · source snapshot 45 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A078969-001 GRANISETRON HYDROCHLORIDE GRANISETRON HYDROCHLORIDE EQ 1MG BASE TABLET / ORAL AB 2009-06-22
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 1 matching rows.
Application-product, TE code table Application-product TE code A078969-001 AB
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 2 · 45 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-11-14 07:37:17 2026-10 A078969-001 GRANISETRON HYDROCHLORIDE EQ 1MG BASE TABLET / ORAL AB 2009-06-22 d4dbc9d85df4…2026-10-15 13:18:30 2026-09 A078969-001 GRANISETRON HYDROCHLORIDE EQ 1MG BASE TABLET / ORAL AB 2009-06-22 c2088c7a36db…2026-09-14 22:38:34 2026-08 A078969-001 GRANISETRON HYDROCHLORIDE EQ 1MG BASE TABLET / ORAL AB 2009-06-22 84e616aacf4f…2026-08-18 06:07:40 2026-07 A078969-001 GRANISETRON HYDROCHLORIDE EQ 1MG BASE TABLET / ORAL AB 2009-06-22 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 A078969-001 GRANISETRON HYDROCHLORIDE EQ 1MG BASE TABLET / ORAL AB 2009-06-22 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A078969-001 GRANISETRON HYDROCHLORIDE EQ 1MG BASE TABLET / ORAL AB 2009-06-22 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A078969-001 GRANISETRON HYDROCHLORIDE EQ 1MG BASE TABLET / ORAL AB 2009-06-22 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A078969-001 GRANISETRON HYDROCHLORIDE EQ 1MG BASE TABLET / ORAL AB 2009-06-22 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A078969-001 GRANISETRON HYDROCHLORIDE EQ 1MG BASE TABLET / ORAL AB 2009-06-22 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A078969-001 GRANISETRON HYDROCHLORIDE EQ 1MG BASE TABLET / ORAL AB 2009-06-22 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A078969-001 GRANISETRON HYDROCHLORIDE EQ 1MG BASE TABLET / ORAL AB 2009-06-22 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A078969-001 GRANISETRON HYDROCHLORIDE EQ 1MG BASE TABLET / ORAL AB 2009-06-22 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A078969-001 GRANISETRON HYDROCHLORIDE EQ 1MG BASE TABLET / ORAL AB 2009-06-22 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 A078969-001 GRANISETRON HYDROCHLORIDE EQ 1MG BASE TABLET / ORAL AB 2009-06-22 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A078969-001 GRANISETRON HYDROCHLORIDE EQ 1MG BASE TABLET / ORAL AB 2009-06-22 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A078969-001 GRANISETRON HYDROCHLORIDE EQ 1MG BASE TABLET / ORAL AB 2009-06-22 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A078969-001 GRANISETRON HYDROCHLORIDE EQ 1MG BASE TABLET / ORAL AB 2009-06-22 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 A078969-001 GRANISETRON HYDROCHLORIDE EQ 1MG BASE TABLET / ORAL AB 2009-06-22 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 A078969-001 GRANISETRON HYDROCHLORIDE EQ 1MG BASE TABLET / ORAL AB 2009-06-22 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 A078969-001 GRANISETRON HYDROCHLORIDE EQ 1MG BASE TABLET / ORAL AB 2009-06-22 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 A078969-001 GRANISETRON HYDROCHLORIDE EQ 1MG BASE TABLET / ORAL AB 2009-06-22 4b0b4de00fa7…2019-12-13 00:20 UTC 2019-12 A078969-001 GRANISETRON HYDROCHLORIDE EQ 1MG BASE TABLET / ORAL AB 2009-06-22 74a2ff9319b5…2022-03-09 01:35 UTC 2022-03 A078969-001 GRANISETRON HYDROCHLORIDE EQ 1MG BASE TABLET / ORAL AB 2009-06-22 bb7c543d1eb4…2021-12-28 21:50 UTC 2021-12 A078969-001 GRANISETRON HYDROCHLORIDE EQ 1MG BASE TABLET / ORAL AB 2009-06-22 782e0a99824c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 A078969-001 GRANISETRON HYDROCHLORIDE EQ 1MG BASE TABLET / ORAL AB 2009-06-22 87673890dc5c…2021-03-12 10:30 UTC 2021-03 A078969-001 GRANISETRON HYDROCHLORIDE EQ 1MG BASE TABLET / ORAL AB 2009-06-22 5aa47cf7b7d7…2020-12-22 03:56 UTC 2020-12 A078969-001 GRANISETRON HYDROCHLORIDE EQ 1MG BASE TABLET / ORAL AB 2009-06-22 8869cabd3fbd…2020-11-12 02:37 UTC 2020-11 A078969-001 GRANISETRON HYDROCHLORIDE EQ 1MG BASE TABLET / ORAL AB 2009-06-22 c0c555d07b60…2019-12-14 00:12 UTC 2019-12 A078969-001 GRANISETRON HYDROCHLORIDE EQ 1MG BASE TABLET / ORAL AB 2009-06-22 3f01610625f2…2019-09-15 20:21 UTC 2019-09 A078969-001 GRANISETRON HYDROCHLORIDE EQ 1MG BASE TABLET / ORAL AB 2009-06-22 b00525d2431f…2019-07-19 19:46 UTC 2019-07 A078969-001 GRANISETRON HYDROCHLORIDE EQ 1MG BASE TABLET / ORAL AB 2009-06-22 ea99ee380514…2024-03-16 18:09 UTC · 4 captures of this ZIP 2024-03 A078969-001 GRANISETRON HYDROCHLORIDE EQ 1MG BASE TABLET / ORAL AB 2009-06-22 6a51e52b5d6a…2024-02-18 07:12 UTC 2024-02 A078969-001 GRANISETRON HYDROCHLORIDE EQ 1MG BASE TABLET / ORAL AB 2009-06-22 1c564ffb4f44…2023-12-20 04:57 UTC 2023-12 A078969-001 GRANISETRON HYDROCHLORIDE EQ 1MG BASE TABLET / ORAL AB 2009-06-22 ea1830bbd6c7…2023-11-28 05:40 UTC · 2 captures of this ZIP 2023-11 A078969-001 GRANISETRON HYDROCHLORIDE EQ 1MG BASE TABLET / ORAL AB 2009-06-22 a72a2bbeb626…2023-10-25 00:34 UTC · 2 captures of this ZIP 2023-10 A078969-001 GRANISETRON HYDROCHLORIDE EQ 1MG BASE TABLET / ORAL AB 2009-06-22 9b2671bbb829…2023-07-15 15:27 UTC · 2 captures of this ZIP 2023-07 A078969-001 GRANISETRON HYDROCHLORIDE EQ 1MG BASE TABLET / ORAL AB 2009-06-22 a67488948f0b…2023-06-13 01:57 UTC · 3 captures of this ZIP 2023-06 A078969-001 GRANISETRON HYDROCHLORIDE EQ 1MG BASE TABLET / ORAL AB 2009-06-22 3f0d92c62455…2023-05-13 08:27 UTC 2023-05 A078969-001 GRANISETRON HYDROCHLORIDE EQ 1MG BASE TABLET / ORAL AB 2009-06-22 053a50430f4f…2023-01-26 05:58 UTC 2023-01 A078969-001 GRANISETRON HYDROCHLORIDE EQ 1MG BASE TABLET / ORAL AB 2009-06-22 3bdfa0b2c4d7…
Observed Orange Book normalized TE history# Normalized TE history page 2 of 2 · 45 observed states.
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed Product Concepts# FDA-Initiated Inactive NDC Indexing# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 67877-184-02 Granisetron Hydrochloride 2 in 1 BLISTER PACK TABLET 2 4 67877-184-20 Granisetron Hydrochloride 20 in 1 BLISTER PACK TABLET 20 4
DailyMed Socrata Ingredients# Ingredient, Type, UNII table Ingredient Type UNII DailyMed label SPL version Uploaded GRANISETRON HYDROCHLORIDE ACTIVE INGREDIENT 318F6L70J8 GRANISETRON HYDROCHLORIDE TABLET [ASCEND LABORATORIES, LLC] 4 GRANISETRON ACTIVE MOIETY WZG3J2MCOL GRANISETRON HYDROCHLORIDE TABLET [ASCEND LABORATORIES, LLC] 4 CELLULOSE, MICROCRYSTALLINE INACTIVE INGREDIENT OP1R32D61U GRANISETRON HYDROCHLORIDE TABLET [ASCEND LABORATORIES, LLC] 4 HYPROMELLOSES INACTIVE INGREDIENT 3NXW29V3WO GRANISETRON HYDROCHLORIDE TABLET [ASCEND LABORATORIES, LLC] 4 LACTOSE MONOHYDRATE INACTIVE INGREDIENT EWQ57Q8I5X GRANISETRON HYDROCHLORIDE TABLET [ASCEND LABORATORIES, LLC] 4 MAGNESIUM STEARATE INACTIVE INGREDIENT 70097M6I30 GRANISETRON HYDROCHLORIDE TABLET [ASCEND LABORATORIES, LLC] 4 POLYETHYLENE GLYCOL 4000 INACTIVE INGREDIENT 4R4HFI6D95 GRANISETRON HYDROCHLORIDE TABLET [ASCEND LABORATORIES, LLC] 4 POLYSORBATE 80 INACTIVE INGREDIENT 6OZP39ZG8H GRANISETRON HYDROCHLORIDE TABLET [ASCEND LABORATORIES, LLC] 4 SODIUM STARCH GLYCOLATE TYPE A POTATO INACTIVE INGREDIENT 5856J3G2A2 GRANISETRON HYDROCHLORIDE TABLET [ASCEND LABORATORIES, LLC] 4 TITANIUM DIOXIDE INACTIVE INGREDIENT 15FIX9V2JP GRANISETRON HYDROCHLORIDE TABLET [ASCEND LABORATORIES, LLC] 4
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 67877-184 GRANISETRON HYDROCHLORIDE TABLET [ASCEND LABORATORIES, LLC] 4 Legacy NDC, 2 package rows 20110323_65d31bc7-c6a6-4515-8e3a-93e0754540b2.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 2 matching rows.
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Status 67877-184-02 67877018402 2 in 1 BLISTER PACK Historical 67877-184-20 67877018420 20 in 1 BLISTER PACK Historical